Cargando…
Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth
The chromatin modifier PRDM2/RIZ1 is inactivated by mutation in several forms of cancer and is a putative tumor suppressor gene. Frameshift mutations in the C-terminal region of PRDM2, affecting (A)8 or (A)9 repeats within exon 8, are found in one third of colorectal cancers with microsatellite inst...
Autores principales: | Pandzic, Tatjana, Rendo, Veronica, Lim, Jinyeong, Larsson, Chatarina, Larsson, Jimmy, Stoimenov, Ivaylo, Kundu, Snehangshu, Ali, Muhammad Akhtar, Hellström, Mats, He, Liqun, Lindroth, Anders M., Sjöblom, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716757/ https://www.ncbi.nlm.nih.gov/pubmed/29228717 http://dx.doi.org/10.18632/oncotarget.21713 |
Ejemplares similares
-
Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition
por: Larsson, Chatarina, et al.
Publicado: (2017) -
Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression
por: Larsson, Chatarina, et al.
Publicado: (2020) -
Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015) -
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
por: Rendo, Veronica, et al.
Publicado: (2020) -
Targeting tumor vulnerabilities associated with loss of heterozygosity
por: Rendo, Veronica, et al.
Publicado: (2020)